Author:
Jia Siyue,Zhu Wenbo,Jiang Hudachuan,Zhu Fengcai
Publisher
Science China Press., Co. Ltd.
Reference36 articles.
1. ESMO. COVID-19 vaccination in cancer patients: ESMO Statements. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination (4 October 2021, date last accessed).
2. He Y, Ding Y, Cao B. COVID-19 vaccine development from the perspective of cancer patients. Hum Vaccines Immunother, 2021, 17: 3281-3287.
3. Ribas A, Sengupta R, Locke T. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov, 2021, 11: 233-236.
4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA, 2020, 323:
5. Meng Y, Lu W, Guo E. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol, 2020, 13:
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The evolving immunity to SARS-CoV-2;National Science Open;2022-04-01